232 related articles for article (PubMed ID: 33868168)
1. High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women.
Li Q; Zheng D; Lin H; Zhong F; Liu J; Wu Y; Wang Z; Guan Q; Zhao M; Gao L; Zhao J
Front Endocrinol (Lausanne); 2021; 12():627903. PubMed ID: 33868168
[TBL] [Abstract][Full Text] [Related]
2. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women.
Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Miura M; Irahara M
J Endocrinol Invest; 2006 Nov; 29(10):913-8. PubMed ID: 17185901
[TBL] [Abstract][Full Text] [Related]
3. Hormone profile of menopausal women in Havana.
Navarro D; Acosta A; Robles E; Díaz C
MEDICC Rev; 2012 Apr; 14(2):13-5. PubMed ID: 22580548
[TBL] [Abstract][Full Text] [Related]
4. A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80.
Zhu Y; Xu J; Zhang X; Ke Y; Fu G; Guo Q
BMC Geriatr; 2021 Oct; 21(1):544. PubMed ID: 34641807
[TBL] [Abstract][Full Text] [Related]
5. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
Robyn C; Vekemans M
Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
[TBL] [Abstract][Full Text] [Related]
6. Cycle and hormone changes during perimenopause: the key role of ovarian function.
Burger HG; Hale GE; Dennerstein L; Robertson DM
Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
[TBL] [Abstract][Full Text] [Related]
7. Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999-2000)*.
Henrich JB; Hughes JP; Kaufman SC; Brody DJ; Curtin LR
Menopause; 2006; 13(2):171-7. PubMed ID: 16645530
[TBL] [Abstract][Full Text] [Related]
8. Effects of Sex Hormones and Age on Brain Volume in Post-Menopausal Women.
Kim GW; Park K; Jeong GW
J Sex Med; 2018 May; 15(5):662-670. PubMed ID: 29628218
[TBL] [Abstract][Full Text] [Related]
9. Low pulse oxygen saturation in post-menopausal women at high altitude is related to a high serum testosterone/estradiol ratio.
Gonzales GF; Villena A
Int J Gynaecol Obstet; 2000 Nov; 71(2):147-54. PubMed ID: 11064012
[TBL] [Abstract][Full Text] [Related]
10. Serum Follicle-Stimulating Hormone Levels Are Associated with Cardiometabolic Risk Factors in Post-Menopausal Korean Women.
Jung ES; Choi EK; Park BH; Chae SW
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32325717
[No Abstract] [Full Text] [Related]
11. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women.
Wide L; Naessén T; Phillips DJ
Clin Endocrinol (Oxf); 1995 Jan; 42(1):59-64. PubMed ID: 7889633
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer.
Eskelinen M; Nordén T; Lindgren A; Wide L; Adami HO; Holmberg L
Eur J Surg Oncol; 2004 Jun; 30(5):495-500. PubMed ID: 15135476
[TBL] [Abstract][Full Text] [Related]
13. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.
Crandall CJ; Tseng CH; Crawford SL; Thurston RC; Gold EB; Johnston JM; Greendale GA
J Bone Miner Res; 2011 Apr; 26(4):840-9. PubMed ID: 20878774
[TBL] [Abstract][Full Text] [Related]
14. Changes in kidney function during the menopausal transition: the Study of Women's Health Across the Nation (SWAN) - Michigan site.
Kim C; Saran R; Hood M; Karvonen-Gutierrez C; Peng MQ; Randolph JF; Harlow SD
Menopause; 2020 Sep; 27(9):1066-1069. PubMed ID: 32852461
[TBL] [Abstract][Full Text] [Related]
15. Serum follicle-stimulating hormone and luteinizing hormone levels in women aged 35-60 in the U.S. population: the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994).
Backer LC; Rubin CS; Marcus M; Kieszak SM; Schober SE
Menopause; 1999; 6(1):29-35. PubMed ID: 10100177
[TBL] [Abstract][Full Text] [Related]
16. Decrease in melatonin precedes follicle-stimulating hormone increase during perimenopause.
Vakkuri O; Kivelä A; Leppäluoto J; Valtonen M; Kauppila A
Eur J Endocrinol; 1996 Aug; 135(2):188-92. PubMed ID: 8810731
[TBL] [Abstract][Full Text] [Related]
17. Sleep During Menopausal Transition: A 6-Year Follow-Up.
Lampio L; Polo-Kantola P; Himanen SL; Kurki S; Huupponen E; Engblom J; Heinonen OJ; Polo O; Saaresranta T
Sleep; 2017 Jul; 40(7):. PubMed ID: 28525646
[TBL] [Abstract][Full Text] [Related]
18. Associations of follicle-stimulating hormone and luteinizing hormone with metabolic syndrome during the menopausal transition from the National Health and Nutrition Examination Survey.
Chen Y; Wang C; Sun B; Wang B; Lu X; Gao B; Cao Y; Zhou J; Liu X
Front Endocrinol (Lausanne); 2023; 14():1034934. PubMed ID: 36843613
[TBL] [Abstract][Full Text] [Related]
19. Increase in circulating sclerostin at the early stage of menopausal transition in Japanese women.
Matsui S; Yasui T; Kasai K; Keyama K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
Maturitas; 2016 Jan; 83():72-7. PubMed ID: 26508082
[TBL] [Abstract][Full Text] [Related]
20. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
